跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
A-17
首页
药物
A-17
A-17
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Methods of using IL-17 receptor A antibodies
申请人: AMGEN INC
优先权: 2007
US
23 件公开
17.Beta.-Fluoromethoxycarbonyl-Androst-4-En-3-One Compounds With a 17.Alpha.-Carbonate Sustituent
申请人: BIGGADIKE KEITH
优先权: 2005
US
KERATIN 17 AS A BIOMARKER FOR BLADDER CANCER
申请人: UNIV NEW YORK STATE RES FOUND
优先权: 2016
CN
EP
US
4 件公开
Method of treating multiple myeloma using 17-AAG or 17-AG or a prodrug of either
申请人: JOHNSON ROBERT G JR
优先权: 2006
US
2 件公开
Keratin 17 as a prognostic marker for pancreatic cancer
申请人: UNIV NEW YORK STATE RES FOUND
优先权: 2016
US
USE OF IL-17 RECEPTOR A ANTIGEN BINDING PROTEINS
申请人: MARTIN DAVID ANDREW
优先权: 2010
US
Method of treating breast cancer using 17-aag or 17-ag or a prodrug of either in combination with a her2 inhibitor
申请人: KOSAN BIOSCIENCES INC
优先权: 2005
CN
Method of treating multiple myeloma using 17-AAG or 17-AG or a prodrug of either in combination with a proteasome inhibitor
申请人: JOHNSON ROBERT G JR
优先权: 2006
US
药物
反馈